AR and prostate carcinoma: Haffner et al. also reported that androgen signaling promotes co-recruitment of AR and topoisomerase II beta (TOP2B) to the genomic breakpoints sites, triggering recombinogenic AR- and TOP2B-mediated DSBs that are found in DHT-stimulated prostate cancer cells30.